Login
Home
Charts
Search
Watchlist
Products

KMC Speciality Hospitals (India) Ltd

KMCSHIL·BSE
162.50+1.69%Wed, 23 Sept '26

KMC Speciality Hospitals (India) Ltd

KMCSHIL
BSE
162.50
+1.69%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
2,650Cr
Close
Close Price
162.50
Industry
Industry
Hospitals
PE
Price To Earnings
47.51
PS
Price To Sales
8.01
Revenue
Revenue
331Cr
Rev Gr TTM
Revenue Growth TTM
35.06%
PAT Gr TTM
PAT Growth TTM
137.83%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
424945535661616775828292
Growth YoY
Revenue Growth YoY%
6.922.79.329.932.924.935.725.433.233.735.037.9
Expenses
ExpensesCr
313533404445465054575663
Operating Profit
Operating ProfitCr
111412131316151621252628
OPM
OPM%
26.329.326.324.422.326.125.324.727.830.231.531.0
Other Income
Other IncomeCr
111101111122
Interest Expense
Interest ExpenseCr
001232222222
Depreciation
DepreciationCr
223455555566
PBT
PBTCr
9129751091015182022
Tax
TaxCr
232213424556
PAT
PATCr
7976485811141517
Growth YoY
PAT Growth YoY%
-2.050.4-2.3-20.6-43.5-20.9-36.336.8179.482.8223.7119.8
NPM
NPM%
16.219.315.810.46.912.27.411.314.516.717.818.1
EPS
EPS
0.40.60.40.30.20.50.30.50.70.80.91.0
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
424945535661616775828292
Growth YoY
Revenue Growth YoY%
6.922.79.329.932.924.935.725.433.233.735.037.9
Expenses
ExpensesCr
313533404445465054575663
Operating Profit
Operating ProfitCr
111412131316151621252628
OPM
OPM%
26.329.326.324.422.326.125.324.727.830.231.531.0
Other Income
Other IncomeCr
111101111122
Interest Expense
Interest ExpenseCr
001232222222
Depreciation
DepreciationCr
223455555566
PBT
PBTCr
9129751091015182022
Tax
TaxCr
232213424556
PAT
PATCr
7976485811141517
Growth YoY
PAT Growth YoY%
-2.050.4-2.3-20.6-43.5-20.9-36.336.8179.482.8223.7119.8
NPM
NPM%
16.219.315.810.46.912.27.411.314.516.717.818.1
EPS
EPS
0.40.60.40.30.20.50.30.50.70.80.91.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4355718296103136156177232306331
Growth
Revenue Growth%
17.328.828.916.416.96.732.614.513.830.732.035.1
Expenses
ExpensesCr
35435766757999114130175218231
Operating Profit
Operating ProfitCr
812141621233741475788100
OPM
OPM%
18.622.420.019.421.922.627.326.526.824.628.830.2
Other Income
Other IncomeCr
100212234356
Interest Expense
Interest ExpenseCr
211111111988
Depreciation
DepreciationCr
334456789192222
PBT
PBTCr
4810121718323641326375
Tax
TaxCr
1334558910101620
PAT
PATCr
35791213242730214756
Growth
PAT Growth%
2,493.866.624.229.436.48.885.712.513.8-29.5118.1137.8
NPM
NPM%
7.59.89.410.512.212.417.417.117.19.315.316.9
EPS
EPS
0.20.30.40.50.70.81.41.61.91.32.93.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4355718296103136156177232306331
Growth
Revenue Growth%
17.328.828.916.416.96.732.614.513.830.732.035.1
Expenses
ExpensesCr
35435766757999114130175218231
Operating Profit
Operating ProfitCr
812141621233741475788100
OPM
OPM%
18.622.420.019.421.922.627.326.526.824.628.830.2
Other Income
Other IncomeCr
100212234356
Interest Expense
Interest ExpenseCr
211111111988
Depreciation
DepreciationCr
334456789192222
PBT
PBTCr
4810121718323641326375
Tax
TaxCr
1334558910101620
PAT
PATCr
35791213242730214756
Growth
PAT Growth%
2,493.866.624.229.436.48.885.712.513.8-29.5118.1137.8
NPM
NPM%
7.59.89.410.512.212.417.417.117.19.315.316.9
EPS
EPS
0.20.30.40.50.70.81.41.61.91.32.93.4

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1616161616161616161616
Reserves
ReservesCr
-38142334477097127148194
Current Liabilities
Current LiabilitiesCr
1010121212132023463843
Non Current Liabilities
Non Current LiabilitiesCr
641187292246748479
Total Liabilities
Total LiabilitiesCr
2938536070105129182264286332
Current Assets
Current AssetsCr
3481318264252343381
Non Current Assets
Non Current AssetsCr
27344547527986130230253251
Total Assets
Total AssetsCr
2938536070105129182264286332
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1616161616161616161616
Reserves
ReservesCr
-38142334477097127148194
Current Liabilities
Current LiabilitiesCr
1010121212132023463843
Non Current Liabilities
Non Current LiabilitiesCr
641187292246748479
Total Liabilities
Total LiabilitiesCr
2938536070105129182264286332
Current Assets
Current AssetsCr
3481318264252343381
Non Current Assets
Non Current AssetsCr
27344547527986130230253251
Total Assets
Total AssetsCr
2938536070105129182264286332

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
610121611262932385879
Investing Cash Flow
Investing Cash FlowCr
-1-4-19-9-8-43-29-48-56-51-17
Financing Cash Flow
Financing Cash FlowCr
-5-56-5-418-11621-2-21
Net Cash Flow
Net Cash FlowCr
01-11-11003441
Free Cash Flow
Free Cash FlowCr
56-3137-1516-12-37-6
CFO To PAT
CFO To PAT%
178.4187.8186.5183.991.1200.3122.7121.1126.5268.7169.3
CFO To EBITDA
CFO To EBITDA%
72.581.787.899.050.7110.278.378.281.1101.290.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
610121611262932385879
Investing Cash Flow
Investing Cash FlowCr
-1-4-19-9-8-43-29-48-56-51-17
Financing Cash Flow
Financing Cash FlowCr
-5-56-5-418-11621-2-21
Net Cash Flow
Net Cash FlowCr
01-11-11003441
Free Cash Flow
Free Cash FlowCr
56-3137-1516-12-37-6
CFO To PAT
CFO To PAT%
178.4187.8186.5183.991.1200.3122.7121.1126.5268.7169.3
CFO To EBITDA
CFO To EBITDA%
72.581.787.899.050.7110.278.378.281.1101.290.0

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1292122932522043569089381,3241,0011,2842,650
Price To Earnings
Price To Earnings
39.439.443.829.117.427.938.435.143.646.927.447.5
Price To Sales
Price To Sales
3.03.94.13.12.13.56.76.07.54.34.28.0
Price To Book
Price To Book
9.68.89.76.44.05.610.58.39.26.16.112.6
EV To EBITDA
EV To EBITDA
17.117.521.315.89.515.824.323.029.219.014.926.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
71.873.673.274.875.450.653.152.653.954.356.756.7
OPM
OPM%
18.622.420.019.421.922.627.326.526.824.628.830.2
NPM
NPM%
7.59.89.410.512.212.417.417.117.19.315.316.9
ROCE
ROCE%
27.133.625.428.830.620.628.422.518.516.224.324.3
ROE
ROE%
24.022.321.922.023.220.227.323.521.213.022.222.2
ROA
ROA%
10.914.112.614.516.812.218.414.711.57.514.114.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1292122932522043569089381,3241,0011,2842,650
Price To Earnings
Price To Earnings
39.439.443.829.117.427.938.435.143.646.927.447.5
Price To Sales
Price To Sales
3.03.94.13.12.13.56.76.07.54.34.28.0
Price To Book
Price To Book
9.68.89.76.44.05.610.58.39.26.16.112.6
EV To EBITDA
EV To EBITDA
17.117.521.315.89.515.824.323.029.219.014.926.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
71.873.673.274.875.450.653.152.653.954.356.756.7
OPM
OPM%
18.622.420.019.421.922.627.326.526.824.628.830.2
NPM
NPM%
7.59.89.410.512.212.417.417.117.19.315.316.9
ROCE
ROCE%
27.133.625.428.830.620.628.422.518.516.224.324.3
ROE
ROE%
24.022.321.922.023.220.227.323.521.213.022.222.2
ROA
ROA%
10.914.112.614.516.812.218.414.711.57.514.114.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
KMC Speciality Hospitals is a single-campus tertiary-care hospital in Trichy, Tamil Nadu, operating under the “Kauvery Hospital” brand - a name built over 25 years by its clinician-founders. The company was incorporated in 1982, acquired by its current parent in 2008 when it had 250 beds, and transformed in early 2024 when it opened a dedicated 200-bed mother-and-child block called “Maa Kauvery” on the same campus, doubling its capacity to 450 beds in one stroke. Everything the company does flows from a single idea: put a full-spectrum hospital - from routine deliveries to organ transplants - in a regional city, staff it with senior clinicians, and make advanced care accessible to patients who would otherwise travel to a metro. # Business segments One business, one campus - a 450-bed multi-speciality hospital in Trichy that earns from in-patient stays, out-patient consultations and pharmacy sales, with a mother-and-child block as its newest growth engine. ## 1. Multi-speciality hospital: a full-service tertiary centre in a regional city **The Trichy campus runs two connected hospitals on one site - a 250-bed legacy block and a 200-bed mother-and-child block - that together cover everything from neurosurgery to bone-marrow transplants for a catchment stretching 200 kilometres around the city.** - **Two blocks, one campus** - the legacy block (250 beds) handles the full specialty mix, while Maa Kauvery (200 beds, opened January 2024) focuses on obstetrics, gynaecology, neonatology and paediatrics, so the hospital can grow its highest-volume service line without displacing other specialties. - **Centres of Excellence anchor the clinical work** - the hospital organises itself around designated centres for Mother & Child Care, Neurosciences, Gastro Sciences, Orthopaedics, Plastic Surgery, Organ Transplants (liver and bone marrow) and Critical Care, which together brought in 90% of FY26 revenue. - **Patients come from a wide rural and small-town radius** - roughly 89% of in-patients travel from eight districts around Tiruchirapalli, with the top three being Tiruchirapalli itself (45%), Pudukkottai (10%) and Thanjavur (9%), meaning the hospital acts as the regional referral hub for cases that cannot be handled locally. - **Revenue is split three ways by payor** - in Q4 FY26, 70% of revenue came from cash-paying patients, 23% from insured or corporate patients, and 7% from the Tamil Nadu government’s health insurance scheme, giving the hospital a predominantly self-pay base with a small but stable public-scheme component. - **The campus is adding land for another 300 beds** - in May 2026 the board approved the purchase of an adjacent one-acre plot on Alexandria Road, to be funded by internal accruals and debt, signalling that the company intends to expand on the same Trichy site rather than build elsewhere. ## 2. Mother-and-child care: the campus growth engine **Maa Kauvery, the 200-bed block opened in 2024, is the single largest revenue contributor among all specialties and the reason the hospital could nearly double its capacity without leaving its existing campus.** - **The biggest specialty by revenue** - Mother & Child Care Services accounted for 27% of FY26 revenue, more than Neurosciences (19%) and Gastro Sciences (12%) combined, making it the hospital’s dominant clinical franchise. - **Built on the same land, not a new location** - the new block was constructed on the existing Trichy campus, so it shares the legacy hospital’s diagnostic equipment, ICUs, labs and administrative backbone, avoiding the cost and complexity of a standalone site. - **Designed for a complete mother-and-child journey** - the block houses labour operating theatres, a paediatric ICU, a neonatal ICU and dedicated obstetric and paediatric teams, meaning a high-risk pregnancy can be managed from delivery through newborn intensive care under one roof. - **Academic seats lock in clinical talent** - the hospital has over 38 DNB and Diploma seats as of December 2024, which helps it attract and retain junior doctors who staff the mother-and-child and other services while building a pipeline of specialists. # Group structure and partners **The company is a 75%-owned listed subsidiary of Sri Kauvery Medical Care, a larger hospital group founded by two anaesthesiologist-entrepreneurs, and it leans on the parent for cardiac care, corporate guarantees and a captive solar arrangement.** - **Parent runs 10 other hospitals** - Sri Kauvery Medical Care operates 12 multi-speciality hospitals with over 2,500 beds across six Tamil Nadu and Karnataka cities; KMC Speciality Hospitals is its Trichy listed entity, holding the two-block campus while the parent runs the rest. - **Cardiac patients are outsourced to the parent** - under the state health insurance scheme, heart patients needing angioplasty or surgery are treated at Kauvery Heart City Hospital, a division of the holding company located on the same premises; KMC receives the scheme payment and reimburses the parent monthly, so it offers cardiac care without running the service itself. - **Cross-guarantees support group borrowing** - the company has provided corporate guarantees to State Bank of India for parent-company loans (up to Rs 98.57 crores as of February 2026), and the parent has reciprocally guaranteed the company’s own borrowings, creating a mutual credit-support structure. - **A 26% stake secures captive solar power** - in September 2025 the company bought a minority stake in Gardenia Energy Private Limited for Rs 26,000, purely to qualify as a captive consumer for solar power supply to the Maa Kauvery unit, not as a financial investment.

Documents — KMC Speciality Hospitals (India) Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/bc1rgij58nv1t9jw0he71k57.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/p1mg1rog2s9es92c3mm5idym.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/vszaxuzo6owidnrx4qvrmx3f.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/7icxyerhcgs7yyimvhkbrj00.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/xwrr9wc2rvt7e2u0lz8f0haf.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/ggx99s1xd3k91fmas4wljdmp.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/vuxmi0tpe0qrycee9r13ccpp.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/tw68j16pudpecxabbxqxil9c.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/ufxj55idjagj4zcj2w3qgnen.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/phflybtiozaq8he6428brtg6.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/4b9b5f9ebnq3vvktlyygk6n7.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/kbrse4g00hv4r0g4bv8kj5te.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/zwdtqgbaizrkrp72luk45ye7.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/5ekygp98xgawaohfvw53qhc8.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/9flfd3oidrj7tm39v0x0sxhj.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/rc02ma8sxr6hmjg32isfh4qc.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/5ug9o7qk202bnvyd7d9q6ilw.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/8yh6q3ai2s20032fsdzu40fn.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/zcgq158xxfgxb59xh5coziur.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/vo0jpt3x40chz3lezrbt1018.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/y7iwgtza4thz5ydc97q3e5kj.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/di8977ci8e5875oazvarpzpp.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/9oardi1b2yls0dmnq9yr5sgp.pdf